acetazolamide Tablets 250 mg

Dossier type
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
Registered in
Manufacturer #461
A pharmaceutical manufacturer based in the EU that is active in 10+ countries selling its products in Europe, Africa, Asia, and LATAM. The company's key therapeutic areas are ophthalmology, dermatology, otorhinolaryngology, and dermo-cosmetics. Key production lines are medicine, medical devices, cosmetics, body care products, and food supplements with GMP. The company does eCTD dossier preparation.

Manufacturer usually replies in 9 days

Acetazolamide is a medication used to treat glaucoma, epilepsy, edema, altitude sickness, hydrocephalus, and hypokalemic periodic paralysis. Suppliers of acetazolamide market it in the form of 250mg and 500mg tablets as well as 500mg powders for an injectable solution.
In use for over 50 years, the drug has since become included in the World Health Organization’s List of Essential Medicines that contain the most important drugs recommended for a basic Health System. There are numerous acetazolamide manufacturers and distributors, with the largest globally being companies Teva, TARO, Zydus Pharmaceuticals, and Lannett.
Acetazolamide suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified acetazolamide manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.
The retail prices per 20 (250mg) tablets of acetazolamide fall into a range of approximately 4,00 EUR to 5,00 EUR.